在患有IgA血管炎炎的儿童中使用特利塔西塞普:初步观察
Jing Wang1, Jingjing Cui1, Jiani Chen1
1Department of Nephrology and Rheumatology, Kunming Children's Hospital, Kunming, China.
Pediatric nephrology (Berlin, Germany)
|March 5, 2025
概括
与标准治疗相结合的特利塔西塞普在患有免疫球蛋白A血管炎炎 (IgAVN) 的儿童中改善了功能. 在这个儿科病例系列中,该治疗证明了良好的安全性和耐受性.
科学领域:
- 儿科脏病学 儿科脏病学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 免疫球蛋白A血管炎炎 (IgAVN) 是儿童病的重要原因.
- 对IgAVN的标准治疗方法,包括葡萄糖皮质类药物和免疫抑制剂,都有局限性.
- 需要新的治疗目标来改善儿科IgAVN患者的治疗结果.
研究的目的:
- 评估telitacicept作为IgAVN诊断的儿童的辅助治疗的安全性和有效性.
- 评估telitacicept对儿科IgAVN的关键实验室标志物和临床结果的影响.
主要方法:
- 一系列病例涉及7名患有活检确认的IgAVN和显著蛋白尿症的儿童.
- 患者在24周内每周接受皮下telitacicept (80或160毫克) 与标准治疗一起.
- 实验室指数,包括蛋白尿,B细胞计数,免疫球蛋白和功能标志物,在治疗前和后进行了分析.
主要成果:
- 泰利塔切治疗导致24小时尿蛋白水平,CD19+B细胞,IgA和IgM显著降低.
- 在治疗后观察到血清白蛋白和补充C4水平的显著增加.
- 血清肌素,血尿素或其他免疫球蛋白/补充剂水平没有显著变化;没有报告药物不良反应.
结论:
- 结合治疗与telitacicept和标准治疗显示了对儿科IgAVN的有希望的临床益处.
- 泰利塔西塞普似乎是一种安全且耐受良好的辅助治疗选择,用于患有IgAVN的儿童.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
98
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
98
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
84
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
84


